Annotation Detail for CHRND
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04080 | Neuroactive ligand-receptor interaction |
Pathway ID | Pathway Name |
---|
| Synaptic Transmission |
Pathway ID | Pathway Name |
---|
P00044 | Nicotinic acetylcholine receptor signaling pathway |
Desease Name |
---|
Brain lesion load |
IMMUNE |
Desease Name |
---|
Brain lesion load |
Desease Name |
---|
Multiple pterygium syndrome, lethal type |
Myasthenic syndrome, fast-channel congenital |
Myasthenic syndrome, slow-channel congenital |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CHRND mRNA | affects expression | 16483693
|
D004390 |
Chlorpyrifos |
Chlorpyrifos affects the expression of CHRND mRNA | affects expression | 18812211
|
D003976 |
Diazinon |
Diazinon affects the expression of CHRND mRNA | affects expression | 17452286
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of CHRND gene | increases mutagenesis | 16495775
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of CHRND mRNA | decreases expression | 18035473
|
C010176 |
halofuginone |
halofuginone results in decreased expression of CHRND mRNA | decreases expression | 17180598
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.02 | 18287403 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.88 | 6695378 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Chlorpyrifos |
10.76 | 17119214 16611668 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Diazinon |
10.76 | 16487989 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.19 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.59 | 16651633 16357521 16436596 15144691 18412241 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
3.93 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.50 | 17160924 |
MESH:D004417 |
Dyspnea |
|
Diazinon |
5.32 | 16487989 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.50 | 18357618 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
4.02 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.59 | 18412241 16357521 16651633 |
MESH:D006505 |
Hepatitis |
|
Diazinon |
4.95 | 16487989 |
MESH:D006965 |
Hyperplasia |
|
halofuginone |
5.66 | 11874485 |
MESH:D007248 |
Infertility, Male |
|
Diazinon |
4.02 | 12948887 16466525 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
2.79 | 17296493 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
4.20 | 17379185 |
MESH:D008103 |
Liver Cirrhosis |
|
halofuginone |
4.18 | 17180598 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
halofuginone |
2.98 | 14739098 18458672 16489207 11172339 12175628 |
MESH:D008107 |
Liver Diseases |
|
Chlorpyrifos |
3.13 | 15991261 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
2.63 | 16019985 6695378 16271038 17703301 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
4.16 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.47 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
3.70 | 18041768 10767621 10838139 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.50 | 17943659 |
OMIM:253290 |
MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE |
marker/mechanism |
|
| |
OMIM:608930 |
MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL |
marker/mechanism |
|
| |
OMIM:601462 |
MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL |
marker/mechanism |
|
| |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.82 | 16707424 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.88 | 16003739 17160924 16651423 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Chlorpyrifos |
4.37 | 15081274 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.50 | 17160924 |
MESH:D011041 |
Poisoning |
|
Diazinon |
4.70 | 17603234 |
MESH:D012135 |
Respiratory Sounds |
|
Chlorpyrifos |
5.05 | 16611668 17119214 11874814 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Chlorpyrifos |
5.41 | 16611668 17119214 |
MESH:D012729 |
Sex Chromosome Aberrations |
|
Chlorpyrifos |
6.61 | 6418539 |
MESH:D012871 |
Skin Diseases |
|
halofuginone |
3.57 | 11874485 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.62 | 15790496 |
MESH:D014570 |
Urologic Diseases |
|
Diazinon |
5.80 | 16487989 |
Pathway ID |
Pathway Name |
---|
KEGG:04080 |
Neuroactive ligand-receptor interaction |
REACT:13685 |
Synaptic Transmission |
PharmGKB Accession:PA26497
Releated disease ID |
Related disease Name |
PA152238425 | Multiple Pterygium Syndrome |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00674 |
allosteric modulator |
Galantamine |
Parasympathomimetics;Cholinesterase Inhibitors;Nootropic Agents |